Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Cobimetinib

0873dc16-6964-5b66-9fa5-8388ccd977e8 · FDA Approved · targets MEK1, MEK2

Cobimetinib

MeasuredReference

Cobimetinib has no high-confidence primary targets in the catalog.

Primary targets

No high-confidence primary targets.

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Cobimetinib

MeasuredReference

1 known oncogenic variants exist on Cobimetinib's top targets — see detail for inhibition impact.

Open in new tab